The world’s leading community for biotechnology supply chain professionals will be meeting at the Embassy Suites in South San Francisco on October 26, 2010, for the 3rd annual Biotech Supply Chain Academy conference. The expanded multi-track conference titled “Transforming the Global Supply Chain for End-to-End Visibility and Quality Patient Care” will be identifying and developing supply chain solutions for the industry’s expanding world presence with a clear focus on patient care. The Call for Papers requests expert speakers to present on topics enumerated below and others deemed pertinent and valuable. The deadline for paper submissions is August 1, 2010.
Industry and Academia leaders from around the world will present a large slate of sessions designed to increase collaboration and cooperation between suppliers, manufacturers, distributors, and providers. The focus of the conference will be the Top 10 issues facing the biotech industry:
1. Biotech Industry Research from Wall Street, Venture Capital and Manufacturing Industry Experts
2. Development of Supply Chain Talent Management: Practices from the Best in Other Industries and Academia
3. Creating the Patient-focused Supply Chain: Best Practices for the Identification, Measurement, and Execution of Risk Management
4. Information Technology Management: The Holy Grail! Technical Solutions to Enable Procure to Pay and ePedigree
5. Global Strategic Sourcing: Sourcing Development Strategies in a Collaborative Environment to Maximize Supplier and Vendor Relationships
6. Visibility in the Supply Chain: Proven Solutions from End-to-End
7. Cash Management: Ensuring the Financial Bottom Line of SCM
8. Applying Lean Six Sigma and QA to Optimize Patient Care and Eliminate Waste
9. Cold Chain & Logistics Management: Technologies and Best of Breed Case Studies
10. CRO, CMO, R&D and Business Analytics Services: The New Outsourcing Frontiers of India, China and Europe
“The executive and academic leaders of the biotech industry have built a strong foundation for the discussion of challenges, exchange of solutions, and implementation of advancements in the supply chain in an open, collaborative manner,” says Devendra Mishra, the executive director of the Bio Supply Management Alliance (BSMA) and adjunct professor of Pepperdine University’s Graziadio School of Business and Management. “Today they are committed to fostering the mission of improving the efficacy of the end-to-end supply chain by reducing the drug development pipeline cost and time line through global synergies and developing highly capable supply chain management talent for higher quality patient care.”
The BSMA Board of Advisors are: Alison Moore, Ph.D., Vice President, Corporate Manufacturing, Amgen; Mark Buck, Global Supply Chain and Procurement Leader, Bio-Rad Laboratories;
Because life depends on usTM, the Bio Supply Management Alliance supports B2B networking, continuous learning and career improvement of bio supply management professionals. For more information, go to http://www.biosupplyalliance.org.



